Biosurgical Agents | Market Insights | Latin America (Supplemental) | 2024
The biosurgical agent market in Latin America will observe modest growth through 2032, primarily driven by surgical procedure volume growth, increasing evidence of the clinical benefits of biosurgical agents on surgical outcomes, favorable demographics in the region, innovation and introduction of new products in the market, and expanding indications for biosurgical agents.
This Medtech 360 Report provides high-level market metrics for biosurgical agents in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America from 2019 through 2032.
